ARTICLEGlutamate and the Treatment of Obsessive-Compulsive DisorderMacMaster, Frank P. PhD; Rosenberg, David R. MDSection Editor(s): Janicak, Philip G. MD Author Information Dr. MacMaster is Postdoctoral Research Assistant, and Dr. Rosenberg is Professor, Chief of Child Psychiatry and Psychology, Wayne State University School of Medicine, Children's Hospital of Michigan, 9B-UHC Psychiatry, 4201 St. Antoine, Detroit, MI 48201; E-mail: [email protected]. Dr. Rosenberg has disclosed that he has received grant support from Ortho-McNeil Janssen Scientific Affairs LLC. Dr. MacMaster and all editors and staff in a position to control the content of this CME activity and their spouses/life partners (if any) have disclosed that they have no financial relationships with, or financial interests in, any commercial companies pertaining to this educational activity. The authors also disclosed that the use of riluzole, lamotrigine, topiramate, n-acetylcysteine, d-cycloserine, and memantine as discussed in this article for treatment of obsessive-compulsive disorder has not been approved by the U.S. Food and Drug Administration. Lippincott CME Institute, Inc., has identified and resolved all faculty conflicts of interest regarding this educational activity. Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Lippincott Continuing Medical Education Institute, Inc., designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. To earn CME credit, you must read the CME article(s) and complete the quiz and evaluation assessment survey on the enclosed form, answering at least 80% of the quiz questions correctly. This activity expires on April 30, 2011. Psychopharm Review: May 2010 - Volume 45 - Issue 5 - p 33-39 doi: 10.1097/01.IDT.0000371058.38341.b3 Buy Take the CME Test Metrics © 2010 Lippincott Williams & Wilkins, Inc.